2013

Quast SA, Berger A, Eberle J:
ROS-dependent Bax phosphorylation by the kinase inhibitor wortmannin sensitizes melanoma cells for TRAIL-induced apoptosis.
Cell Death Dis 4: e839 (2013)


Glas M, Coch C, Trageser D, Dassler J, Simon M, Koch P, Mertens J, Quandel T, Gorris R, Reinartz R, Wieland A, Von Lehe M, Pusch A, Roy K, Schlee M, Neumann H, Fimmers R, Herrlinger U, Brüstle O, Hartmann G, Besch R, Scheffler B:
Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma.
Stem Cells 31 (6): 1064-1074 (2013)


Hohenauer T, Berking C, Schmidt A, Haferkamp S, Senft D, Kammerbauer C, Fraschka S, Graf SA, Irmler M, Beckers J, Flaig M, Aigner A, Höbel S, Hoffmann F, Hermeking H, Rothenfusser S, Endres S, Ruzicka T, Besch R:
The neural crest transcription factor Brn3a is expressed in melanoma and required for cell cycle progression and survival.
EMBO Molecular Medicine 5: 919-934 (2013)


Luo C, Merz PR, Chen Y, Dickes E, Pscherer A, Schadendorf D, Eichmüller SB:  MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Cancer Lett 341 (2): 240-247 (2013)


Schmid R, Meyer K, Spang R, Schittek B, Bosserhoff AK:
MIA promotes melanoma development through activation of YBX1.
Pigment Cell Melanoma Res 26 (5): 685-696 (2013)


Schmid R, Meyer K, Spang R, Schittek B, Bosserhoff AK:
YBX1 Is a Modulator of MIA/CD-RAP-Dependent Chondrogenesis.
PLoS One 8 (12): e82166 (2013)


Schaafhausen M, Yang WJ, Centanin L, Wittbrodt J, Bosserhoff A, Fischer A, Schartl M, Meierjohann S:
Tumor angiogenesis is caused by single melanoma cells in a reactive oxygen species and NFkappaB dependent manner.
J Cell Sci 126: 3862-3872 (2013)


Erben F, Kleeblatt D, Sonneck M, Hein M, Feist H, Fahrenwaldt T, Fischer C, Matin A, Iqbal J, Plötz M, Eberle J, Langer P:
Synthesis and antiproliferative activity of selenoindirubins and selenoindirubin-N-glycosides.
Org Biomol Chem 11 (24): 3963-3978 (2013)


Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhövel S, Hufnagel AL, Houben R, Meierjohann S:
Vemurafenib induces senescence features in melanoma cells.
J Invest Dermatol 133 (6): 1601-1609 (2013)


Berger A, Quast SA, Plötz M, Kammermeier A, Eberle J:
Sensitization of melanoma cells for TRAIL-induced apoptosis by BMS-345541 correlates with altered phosphorylation and activation of Bax.
Cell Death Dis 4: e477 (2013)

 

Luo C, Tetteh PW, Merz PR, Dickes E, Abukiwan A, Hotz-Wagenblatt A, Holland-Cunz S, Sinnberg T, Schittek B, Schadendorf D, Diederichs S, Eichmüller SB:
miR-137 Inhibits the Invasion of Melanoma Cells through Downregulation of Multiple Oncogenic Target Genes.
J Invest Dermatol 133 (3): 768-775 (2013)

 

Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff AK:
MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Oncogene32 (24):2984-2991 (2013)

Aktuelles

"Melanomverbund meets ADO" vom 11.-13.9.2014

Beim 24. Deutschen Hautkrebskongress (11.-13. September 2014, Kap Europa Frankfurt) ist auch der...

Deutscher Krebspreis 2014

Prof. Christoph Klein, Projektleiter im Melanomverbund, mit dem Deutschen Krebspreis 2014...

2. International Symposium "Trends in Melanoma Research", 11.-13.12.2014, in Regensburg

The Melanoma Research Network "Molecular Mechanisms of Development and Progression of...

Symposium "Trends in Melanoma Research" 2013

We cordially thank you for your participation in our Symposium “Trends in Melanoma research” (June...